Angels for Change was recently featured in an Understood.org article examining how the DEA’s adjustments to stimulant production limits may affect the ongoing ADHD medication shortage.
The article highlights the complex factors contributing to medication access challenges, including quota restrictions, manufacturing capacity, and rising demand.
When a child is told the medicine they need to live isn’t available — we must act for change. The Children’s Hospital Association’s new article, “Ensuring Access to Critical Medicines for Children,” shines a light on the shared effort to protect pediatric patients from drug shortages and features Angels for Change’s work to strengthen medicine access nationwide.
Cancer Therapy Advisor recently published “Drug Shortages Threaten Cancer Care”, featuring insights from Dr. Ken Komorny of Moffitt Cancer Center.
While discussing solutions to address ongoing drug shortages, Dr. Komorny highlighted the work of Angels for Change, noting that “Angels for Change has proposed several ways to prevent or reduce the impact of shortages, including buffer inventory, stewardship, tracking, and early warning systems modeled after those in banking and agriculture.”
The Children’s Hospital Association recently highlighted Angels for Change in their article “Collaborating to End Drug Shortages.” The story explores how hospitals, manufacturers, and advocates are working together to strengthen the pediatric medicine supply chain. Through Project PROTECT, Angels for Change and partners like CHA are proactively safeguarding essential medicines so shortages don’t interrupt patient care. Together, we’re building a stronger, more reliable system that protects every child who depends on lifesaving treatments.
Healthcare Brew explores how Angels for Change is addressing the national drug shortage crisis. From our Drug Shortage Hotline—which has helped patients access more than 750,000 medicines since 2022—to efforts that strengthen supply chains and raise awareness, the article highlights the urgent need for solutions and the impact of collaboration across patients, providers, and industry.
Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain
Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”
Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.
New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch
Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care
Angels for Change supports the Mapping America’s Pharmaceutical Supply (MAPS) Act introduced May 15th. This bipartisan legislation marks a critical step toward addressing the root causes of drug shortages and promoting transparency, accountability, and resilience in the U.S. pharmaceutical supply chain.
Angels for Change (A4C) announces the pilot launch of Project GOLD (Generic Oncology Lifesaving Drugs), a new resiliency program that establishes an onshore buffer supply of six essential medications that are used to treat cancer. Project GOLD was created to offer physicians and patients stability of care during a shortage through emergency supply at leading distributors and manufacturers. A4C is participating with founding pilot members, pharmaceutical wholesalers Cencora and McKesson, and pharmaceutical and medtech manufacturer Fresenius Kabi.
Angels for Change applauds Senator Kaine, Senator Cotton, Representative Spanberger, and Representative Smith for their bipartisan leadership in taking on the drug shortage crisis and advancing this vital work. We are proud to support the End Drug Shortages Act.
How Pharmaceutical Supply Chain Advancements are Meeting the Moment and Beyond panel at Milken Institute Future of Health Summit, moderated by Sarah Karlin-Smith from Citeline, with Panelists Laura Bray from Angels for Change, Shamiram Feinglass MD, MPH from Manatt, Phelps & Phillips, LLP, Kirk Kaminsky from McKesson and Vimala Raghavendran from US Pharmacopeia.
We must work to ensure ALL pediatric cancer patients have access to their life-saving medicines.
We must act together to ensure ALL patients have access to life-saving medications. Read the AMJC article and Sandoz's new report titled, "Solving America's Drug Shortage Dilemma, For Good"
Thank you USA TODAY for highlighting the unique challenges pediatric cancer patients and children's hospitals face during drug shortages. We must ensure every hospital has access to life-saving medicines to properly treat ALL pediatric cancer patients.
Thank you to the Journal of Clinical Pathways for interviewing Chief Change Maker, Laura Bray at the 2024 National Comprehensive Cancer Network annual conference.
Science Friday took a deep dive into the complexities of drug shortages and the patient harm they create.
"It was the question of, is he gonna get what he needs? Are we even gonna be able to have the best chance at beating this?" Kristin Zastoupil mother of a Drug Shortage Warrior said.
“It’s very frustrating because it’s difficult to reach remission with this disease and once you find that magic combination, you want to stick with it as long as possible,” said Christina Shreeve, shortage warrior Gavin’s mother.
Thank you Spotlight on America and Lisa Fletcher for bringing awareness to drug shortages, Laura's work with the White House Task Force, the new HHS preventing drug shortages white paper, and the actionable steps we must take to solve this crisis.
May 2nd, 2024, The News on Merit Street interviewed Chief Change Maker, Laura Bray, who shared our story and how our Shortage Crisis Line and Global Supply Sharing Network works to help patients in need of life-saving medicines.
